MELOXICAM (Page 8 of 8)

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 69097-158-07 Rx ONLY

Meloxicam

Tablets, USP

7.5 mg

PHARMACIST : PLEASE DISPENSE

WITH MEDICATION GUIDE

100 Tablets

Cipla

7.5
(click image for full-size original)

NDC 69097-159-07 Rx ONLY

Meloxicam

Tablets, USP

15 mg

PHARMACIST : PLEASE DISPENSE

WITH MEDICATION GUIDE

100 Tablets

Cipla

15
(click image for full-size original)
MELOXICAM meloxicam tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:69097-158
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
MELOXICAM (MELOXICAM) MELOXICAM 7.5 mg
Inactive Ingredients
Ingredient Name Strength
MAGNESIUM STEARATE
SILICON DIOXIDE
SODIUM CITRATE
Product Characteristics
Color YELLOW Score no score
Shape ROUND Size 8mm
Flavor Imprint Code C;158
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:69097-158-15 1000 TABLET in 1 BOTTLE None
2 NDC:69097-158-07 100 TABLET in 1 BOTTLE None
3 NDC:69097-158-12 500 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA077929 07/19/2006
MELOXICAM meloxicam tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:69097-159
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
MELOXICAM (MELOXICAM) MELOXICAM 15 mg
Inactive Ingredients
Ingredient Name Strength
CELLULOSE, MICROCRYSTALLINE
MAGNESIUM STEARATE
SODIUM STEARATE
Product Characteristics
Color YELLOW Score no score
Shape ROUND Size 10mm
Flavor Imprint Code CIPLA;159
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:69097-159-12 500 TABLET in 1 BOTTLE None
2 NDC:69097-159-07 100 TABLET in 1 BOTTLE None
3 NDC:69097-159-15 1000 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA077929 07/19/2006
Labeler — Cipla USA Inc. (078719707)

Revised: 09/2021 Cipla USA Inc.

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2022. All Rights Reserved.